ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy-Reference-Cited by-同舟云学术

ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy

Published:2015-02 Issue: Volume:69 Page:63-69
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Cusato Jessica,Allegra Sarah,De Nicolò Amedeo,Boglione Lucio,Fatiguso Giovanna,Cariti Giuseppe,Ciancio Alessia,Smedile Antonina,Strona Silvia,Troshina Giulia,Rizzetto Mario,Di Perri Giovanni,D’Avolio Antonio

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference73 articles.

1. New drug targets for hepatitis C and other Flaviviridae viruses;Paula;Infect Disord Drug Targets,2009

2. WHO: WHO. 2013.

3. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C;Barrera;Hepatology,1995

4. Evolving epidemiology of hepatitis C virus;Lavanchy;Clin Microbiol Infect,2011

5. What is the future of ribavirin therapy for hepatitis C?;Koh;Antiviral Res,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress and Challenges in the Use of a Liver-on-a-Chip for Hepatotropic Infectious Diseases;Micromachines;2021-07-19

2. Could polymorphisms in ABCB1 gene represent a genetic risk factor for the development of mammary tumors in dogs?;The Veterinary Journal;2019-06

3. HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study;Clinical Drug Investigation;2019-01-08

4. Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy;Pharmacogenomics;2018-06-01

5. Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients;Infection, Genetics and Evolution;2018-06